MapLight Therapeutics, Inc.
MPLT
$13.71
-$0.24-1.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -101.68% | -171.57% | -274.71% | -54.71% | -62.20% |
| Total Depreciation and Amortization | 8.09% | -2.41% | -27.84% | -27.27% | -21.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 752.61% | 5,322.16% | 48,901.43% | 67.88% | 92.87% |
| Change in Net Operating Assets | 241.58% | 107.71% | -229.25% | -258.77% | -2,475.23% |
| Cash from Operations | -32.10% | -100.31% | -117.93% | -60.12% | -93.74% |
| Capital Expenditure | 66.67% | -- | -254.72% | 91.71% | 77.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 247.01% | 78.75% | -845.16% | -1,603.85% | 114.40% |
| Cash from Investing | 248.19% | 78.69% | -848.76% | -1,669.31% | 114.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,966.67% | 12,920.00% | 1,253,940.91% | 1,385.71% | -98.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -22,805.88% | -328.04% | 91.88% |
| Cash from Financing | 158.97% | -14,476.60% | 5,439,200.00% | 95,780.19% | 90.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 195.43% | -24.57% | -259.63% | 368.62% | 88.17% |